Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
Recruiting
N/A
Interventional Study
Chemotherapy Induced Peripheral Neuropathy
Breast Cancer Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 – 65
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 24 (estimated)
- Sponsor
- Riphah International University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a prevalent and clinically relevant side effect of chemotherapy in breast cancer patients. It occurs in 30-70% of cases. It can cause various sensory and motor symptoms. Specific exercise interventions have proven promising to target relevant symptoms. Therefore, the objective of this study is to determine the effects of Sensorimotor training on…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Females with invasive ductal carcinoma, stages I-III
* Age ranged between 30-65 years
* 3-6 months post breast cancer diagnosis
* Those who have completed chemotherapy treatment and are medically stable
* CIPN symptoms as subjectively assessed by FACT/GOG-Ntx. Score ranges fro…
Contacts